Literature DB >> 23601697

Disease duration-related differences in non-motor symptoms: a study of 616 Chinese Parkinson's disease patients.

Xiaoyan Guo1, Wei Song, Ke Chen, XuePing Chen, Zhenzhen Zheng, Bei Cao, Rui Huang, Bi Zhao, Ying Wu, Hui-Fang Shang.   

Abstract

The differences in non-motor symptoms (NMS) along with the duration of Parkinson's disease (PD) in Chinese populations remain largely unknown. A total of 616 PD patients consisting of 189 patients with disease duration of less than 2years, 239 patients with duration between 2 and 5years, 122 patients with duration between 5 and 10years, and 66 patients with duration more than 10years from Southwest China were studied. Each patient was assessed using the non-motor symptoms scale (NMSS). The mean affected number of NMS was 8.8±5.8, and the mean total NMSS score was 36.3±33.2. The mean affected number of NMS and the mean total NMSS score increased with the disease progression. The following symptoms became more common and severe with the disease duration: falls due to fainting, fatigue, difficulty falling asleep, restless legs, perceptual problem/hallucination domain (i.e., "hallucinations," "delusions," and "double vision"), gastrointestinal domain (i.e., "dribbling saliva," "swallowing," and "constipation"), urinary domain (i.e., "urgency," "frequency," and "nocturia"), and miscellaneous domain (i.e., "excessive sweating"). However, some symptoms such as mood/apathy pleasure, sexual dysfunction, and others remained stable. NMS are prevalent in all disease duration of the Chinese PD patients. Although the mean affected number of NMS and NMMS score increased with the disease duration, NMS progression is symptom specific.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23601697     DOI: 10.1016/j.jns.2013.03.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.

Authors:  Fahd Baig; Michael Lawton; Michal Rolinski; Claudio Ruffmann; Kannan Nithi; Samuel G Evetts; Hugo R Fernandes; Yoav Ben-Shlomo; Michele T M Hu
Journal:  Mov Disord       Date:  2015-07-14       Impact factor: 10.338

2.  Reduced central sympathetic activity in Parkinson's disease.

Authors:  Heidrun H Krämer; Gothje Lautenschläger; Michael de Azevedo; Kathrin Doppler; Anne Schänzer; Christoph Best; Wolfgang H Oertel; Iris Reuter; Claudia Sommer; Frank Birklein
Journal:  Brain Behav       Date:  2019-11-05       Impact factor: 2.708

3.  Predictors of clinically significant quality of life impairment in Parkinson's disease.

Authors:  Diego Santos García; Teresa de Deus Fonticoba; Carlos Cores; Guillermo Muñoz; Jose M Paz González; Cristina Martínez Miró; Ester Suárez; Silvia Jesús; Miquel Aguilar; Pau Pastor; Lluis Planellas; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Inés Legarda; Jorge Hernández Vara; Iria Cabo; Luis López Manzanares; Isabel González Aramburu; María A Ávila Rivera; Maria J Catalán; Víctor Nogueira; Víctor Puente; María Ruíz de Arcos; Carmen Borrué; Berta Solano Vila; María Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo Padilla; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Maria G Alonso Losada; Nuria López Ariztegui; Itziar Gastón; Pedro Clavero; Jaime Kulisevsky; Marta Blázquez Estrada; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Mónica Kurtis; Oriol de Fábregues; Jessica González Ardura; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir
Journal:  NPJ Parkinsons Dis       Date:  2021-12-16

4.  Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.

Authors:  Iris van der Lijn; Gera A de Haan; Famke Huizinga; Fleur E van der Feen; A Wijnand F Rutgers; Catherina Stellingwerf; Teus van Laar; Joost Heutink
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Longitudinal evolution of non-motor symptoms in early Parkinson's disease: a 3-year prospective cohort study.

Authors:  Ruwei Ou; Yanbing Hou; Qianqian Wei; Junyu Lin; Kuncheng Liu; Lingyu Zhang; Zheng Jiang; Bei Cao; Bi Zhao; Wei Song; Huifang Shang
Journal:  NPJ Parkinsons Dis       Date:  2021-07-15

6.  Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Jing Shi; Jinzhou Tian; Ting Li; Bin Qin; Dongsheng Fan; Jingnian Ni; Mingqing Wei; Xuekai Zhang; Na Liu; Jianping Liu; Yumeng Li; Weiwei Liu; Yongyan Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.